Cardioprotective effects of azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia‐reperfusion injury
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardioprotective effects of azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia‐reperfusion injury
Authors
Keywords
-
Journal
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-04-17
DOI
10.1002/jbt.22785
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition
- (2020) Zhiran Ju et al. BIOORGANIC CHEMISTRY
- Obesity, insulin resistance, adiponectin, and PPAR-γ gene expression in broiler chicks fed diets supplemented with fat and green tea (Camellia sinensis) extract
- (2020) F. Mohammadpour et al. DOMESTIC ANIMAL ENDOCRINOLOGY
- Attenuation of ROS-mediated myocardial ischemia–reperfusion injury by morin via regulation of RISK/SAPK pathways
- (2020) Vipin Kumar Verma et al. Pharmacological Reports
- Geraniol protects against cyclophosphamide-induced hepatotoxicity in rats: Possible role of MAPK and PPAR-γ signaling pathways
- (2020) Mahmood Jasim Mohammed et al. FOOD AND CHEMICAL TOXICOLOGY
- Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial
- (2019) Mitsuhide Naruse et al. PLoS One
- Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome
- (2019) Satomi Kagota et al. CARDIOVASCULAR DRUGS AND THERAPY
- Preconditioning with endoplasmic reticulum stress alleviated heart ischemia/reperfusion injury via modulating IRE1/ATF6/RACK1/PERK and PGC-1α in diabetes mellitus
- (2019) Bing Yan et al. BIOMEDICINE & PHARMACOTHERAPY
- Mitochondrial dysfunction/NLRP3 inflammasome axis contributes to angiotensin II-induced skeletal muscle wasting via PPAR-γ
- (2019) Yuqing Liu et al. LABORATORY INVESTIGATION
- Telmisartan inhibits oxalate and calcium oxalate crystal-induced epithelial-mesenchymal transformation via PPAR-γ-AKT/STAT3/p38 MAPK-Snail pathway
- (2019) Yadong Liu et al. LIFE SCIENCES
- Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms
- (2019) Varun Gupta et al. NEUROCHEMISTRY INTERNATIONAL
- Fisetin attenuates isoproterenol-induced cardiac ischemic injury in vivo by suppressing RAGE/NF-κB mediated oxidative stress, apoptosis and inflammation
- (2018) Shanky Garg et al. PHYTOMEDICINE
- Interference With Endothelial PPAR (Peroxisome Proliferator–Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation
- (2018) Anand R. Nair et al. HYPERTENSION
- Febuxostat Modulates MAPK/NF-κBp65/TNF-α Signaling in Cardiac Ischemia-Reperfusion Injury
- (2017) Sana Irfan Khan et al. Oxidative Medicine and Cellular Longevity
- Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury
- (2016) Jinqiao Qian et al. CARDIOVASCULAR DRUGS AND THERAPY
- Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice
- (2014) Sachiko Matsumoto et al. Cardiovascular Diabetology
- Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
- (2012) Shin-ichiro Miura et al. HYPERTENSION RESEARCH
- Structural basis for telmisartan-mediated partial activation of PPAR gamma
- (2012) Yasushi Amano et al. HYPERTENSION RESEARCH
- Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes
- (2011) S. N. Goyal et al. DIABETES OBESITY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started